Abstract

Program Planning and Evaluation is an ongoing process at MSKCC. External scientific review of the Center's basic and clinical research programs is conducted, on an annual basis, by the Center's Board of Scientific Consultants. The review process consists of a two-day meeting including both formal presentations to the Board as well as private interviews by Board members with professional staff. A written report from the board is provided to the President after each annual visit.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-34
Application #
6101431
Study Section
Project Start
1999-02-10
Project End
1999-12-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
34
Fiscal Year
1999
Total Cost
Indirect Cost

  Institution

Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065

  Publications

Fong, Chii Shyang; Ozaki, Kanako; Tsou, Meng-Fu Bryan (2018) PPP1R35 ensures centriole homeostasis by promoting centriole-to-centrosome conversion. Mol Biol Cell 29:2801-2808
García Nores, Gabriela D; Ly, Catherine L; Savetsky, Ira L et al. (2018) Regulatory T Cells Mediate Local Immunosuppression in Lymphedema. J Invest Dermatol 138:325-335
Turcan, Sevin; Makarov, Vladimir; Taranda, Julian et al. (2018) Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nat Genet 50:62-72
Mendez, Joe S; Ostrom, Quinn T; Gittleman, Haley et al. (2018) The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol 20:687-694
Wang, Feng; Li, Hongyan; Markovsky, Ela et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget 9:9311-9324
Wen, Hannah Y; Brogi, Edi (2018) Lobular Carcinoma In Situ. Surg Pathol Clin 11:123-145
Aghajanian, Carol; Bell-McGuinn, Katherine M; Burris 3rd, Howard A et al. (2018) A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors. Invest New Drugs 36:1016-1025
Pun, Shawn C; Landau, Heather J; Riedel, Elyn R et al. (2018) Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. J Am Soc Echocardiogr 31:64-70
Ring, Brian Z; Murali, Rajmohan; Soslow, Robert A et al. (2018) Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study. Cancer Epidemiol Biomarkers Prev 27:680-688
Shukla, Sachet A; Bachireddy, Pavan; Schilling, Bastian et al. (2018) Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. Cell 173:624-633.e8

Showing the most recent 10 out of 8799 publications